In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to establish Protected dosing routine. Supplemental individuals might be enrolled in the identified monotherapy dosign regimen. In Phase B, members will get oral ruxolitinib and ABBV-744 will probably be presented as "insert-on" therapy. In Segment C, https://manleyj655vgq7.develop-blog.com/profile